AEVI GENOMIC MEDICINE INC's ticker is GNMX and the CUSIP is 00835P105. A total of 51 filers reported holding AEVI GENOMIC MEDICINE INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $48,000 | +92.0% | 335,094 | +100.0% | 0.00% | – |
| Q3 2019 | $25,000 | -3.8% | 167,547 | 0.0% | 0.00% | – |
| Q2 2019 | $26,000 | -18.8% | 167,547 | 0.0% | 0.00% | – |
| Q1 2019 | $32,000 | -86.3% | 167,547 | -50.0% | 0.00% | – |
| Q4 2018 | $234,000 | +13.6% | 335,094 | +100.0% | 0.00% | – |
| Q3 2018 | $206,000 | +11.4% | 167,547 | 0.0% | 0.00% | – |
| Q2 2018 | $185,000 | -44.9% | 167,547 | 0.0% | 0.00% | – |
| Q1 2018 | $336,000 | +67.2% | 167,547 | 0.0% | 0.00% | – |
| Q4 2017 | $201,000 | -13.0% | 167,547 | -8.8% | 0.00% | – |
| Q3 2017 | $231,000 | -5.3% | 183,789 | 0.0% | 0.00% | – |
| Q2 2017 | $244,000 | -44.4% | 183,789 | -22.3% | 0.00% | – |
| Q1 2017 | $439,000 | -59.6% | 236,440 | +12.6% | 0.00% | -100.0% |
| Q4 2016 | $1,087,000 | – | 209,910 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 22NW, LP | 155,000 | $206,000 | 0.12% |
| Birchview Capital, LP | 128,000 | $170,000 | 0.09% |
| CARL DOMINO INC | 43,273 | $58,000 | 0.07% |
| NORTHERN CAPITAL MANAGEMENT LLC | 106,050 | $141,000 | 0.05% |
| ELEMENT CAPITAL MANAGEMENT LLC | 124,423 | $165,000 | 0.03% |
| Baker Brothers Advisors | 1,618,089 | $2,152,000 | 0.02% |
| SIMON QUICK ADVISORS, LLC | 24,390 | $32,000 | 0.02% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 31,390 | $42,000 | 0.02% |
| WHITE PINE CAPITAL LLC | 20,000 | $27,000 | 0.01% |
| LMR Partners LLP | 112,265 | $149,000 | 0.01% |